Lucie Loyal (she/her) (@LucieLoyal) header
Lucie Loyal (she/her) (@LucieLoyal) profile picture

Deaf Immunologist // T cell research // Thiel Lab // Berlin Mastodon: @LucieLoyal@mstdn.social

Joined August 2021
Photo by Lucie Loyal (she/her) (@LucieLoyal)Photo by Lucie Loyal (she/her) (@LucieLoyal)
Lucie Loyal (she/her) retweeted
Go @yEFIS! Such a great panel convened on one stage discussing their individual journeys & experiences, raising awareness for visible & invisible obstacles individuals face when navigating the (scientific) system @FaithOsier @SylviaKnapp_Lab @LucieLoyal @Zihai #codeswitching
1
7
1
18
1,629
Lucie Loyal (she/her) retweeted
Looking forward to meeting you at the IUIS meeting in Capetown! On November 29th, @nikolaouch, @NatBennett8 and @Rosalie_Ke from yEFIS will host a panel discussion on equity, diversity, and career development with experts in immunology from minority backgrounds. See you there!
2
12
5
26
9,213
We are looking for a highly motivated PhD candidate with experience in (skin) organoid construction interested to further develop our immune competent skin model and analyze T cell-skin interactions in health and disease. Apply here:
This Post is from an account that no longer exists. Learn more
2
3
904
Lucie Loyal (she/her) retweeted
Das deutsche Wissenschaftssystem rühmt sich hoher Standards hinsichtlich Gleichstellung und Diversität. Doch was ist mit Behinderten? Schwache Quoten an Forschungsinstituten deuten hier auf einen „blinden Fleck“… — Sagt @BMuellerSN in unserem Essayheft: laborjournal.de/rubric/essay…
3
1
6
1,162
Lucie Loyal (she/her) retweeted
Exciting topics at the @Covim_Network meeting on SARS-CoV-2 immunity in Berlin. Thankful to all the speakers and participants of the Collaborative Immunity Platform of the #NUM!
Toller erster Tag des @Covim_Netzwerk Symposiums in Berlin mit interessanten Diskussionen & spannenden Vorträgen zur SARS-CoV-2 Immunität @SawitzkiLab @FKlein_Lab @kischober @marylyn_addo @c_drosten @KUberla @AndreasJThiel @BeateKampmann @c_gaebler @h_gruell @KurthGroup uvm
3
8
3,315
Lucie Loyal (she/her) retweeted
5
11
Lucie Loyal (she/her) retweeted
1/ Hi twitter academia. This is a 🧵on an experience I had at a conference recently. After my oral presentation, I was TOLD that it was not reasonable to pose and test a hypothesis in mice based on observations made in the clinic. I was TOLD this was the WRONG way to do it.
10
56
23
428
You need to do better Germany. Big shout out to those strong women that pioneered. Source: ec.europa.eu/eurostat/web/pr… #WomenInScience
1
16
3
59
Ever wondered how a deaf scientist navigates through academia? nature.com/articles/d41586-0… Disabled people are extremely underrepresented in science - a reduction of barriers and higher sensibility is urgently needed to tap the full potential of diversity
6
32
Lucie Loyal (she/her) retweeted
Go T cells! These couple of weeks we learned a lot thanks to the hard work and the international collaborations of many T cell scientists studying SARS-CoV-2 variants and particularly Omicron. Here is a brief recap👇
13
114
17
383
Lucie Loyal (she/her) retweeted
New from @VirusesImmunology @marioph13 and the @YaleIBIO @YaleMed team Vaccinated people were half as likely to have the virus cultured from their nasopharynx compared with unvaccinated, and that important benefit lasted ~5 months after shots medrxiv.org/content/10.1101/…
33
231
37
742
Lucie Loyal (she/her) retweeted
Much more new beyond 1st look at Omicron vaccine effectiveness, summarized in a terrific thread by @kallmemeg teapawt.net/kallmemeg/status/14693… — ~7% cases Omicron reinfections (0.4% Delta) — 3.2X adjusted odds of household transmission (vs Delta) — big growth advantage👇
NEW: Omicron Variant report from UKHSA Technical Briefing 31 - Omicron Variant (VOC-21NOV-01) assets.publishing.service.go… Updated Omicron Risk Assessment assets.publishing.service.go…
2
49
3
176
Curious how cross-reactivity impacts the buildup of anti SARS-CoV-2 immunity in infection and vaccination and what it has to do with aging? Find our poster 165 at #bsi2021 @britsocimm @ScienceMagazine
5
6
Epitope not mutated in #omicron alternatively defined as immunodominant and protective cross-reactive peptide (S816-830) in this @ScienceMagazine paper by @LucieLoyal @MissesThiel et al. Likely good news for fully vaccinated without immune deficiencies? science.org/doi/10.1126/scie…
2
8
2
23